Rucha Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 1.05 M
- Revenue Growth 49.74%
- Profit Growth 105.12%
- Ebitda 93.02%
- Net Worth 1.07%
- Total Assets 4.02%
About Rucha Pharmaceuticals
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ1994PTC023011
- Company No.
023011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 1994
- Date of AGM
05 Nov 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc-Ahmedabad
Industry
Who are the key members and board of directors at Rucha Pharmaceuticals?
Board Members

No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Rucha Pharmaceuticals.
Rucha Pharmaceuticals Pvt Ltd, for the financial year ended 2018, experienced significant growth in revenue, with a 49.74% increase. The company also saw a substantial improvement in profitability, with a 105.12% increase in profit. The company's net worth moved up by a moderate rise of 1.07%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Rucha Pharmaceuticals?
In 2018, Rucha Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹1.05 M
Charges Breakdown by Lending Institutions
- Uco Bank : 0.10 Cr
- The General Co - Operative Bank Ltd. : 0.01 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
01 Nov 2002 | Uco Bank | ₹0.30 M | Satisfied |
01 Nov 2002 | Uco Bank | ₹0.20 M | Satisfied |
01 Nov 2002 | Uco Bank | ₹0.50 M | Satisfied |
22 Jun 2000 | The General Co - Operative Bank Ltd. | ₹0.05 M | Satisfied |
How Many Employees Work at Rucha Pharmaceuticals?
Unlock and access historical data on people associated with Rucha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Rucha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rucha Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.